1. Colorectal Cancer: Why Does Side Matter?

   • Claire Gallois
   • Simon Pernot
   • Julien Taieb

   Current Opinion 22 May 2018 Pages: 789 - 798

   

2. Vaccines Targeting PCSK9: A Promising Alternative to Passive Immunization with Monoclonal Antibodies in the Management of Hyperlipidaemia?

   • Stefan Weisshaar
   • Markus Zeitlinger

   Leading Article 08 May 2018 Pages: 799 - 808

   

3. Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review

   • Loïc Raffray
   • Loïc Guillevin

   Leading Article 15 May 2018 Pages: 809 - 821

   

4. Management of Embolic Stroke of Undetermined Source (ESUS)

   • Tobias Geisler
   • Annerose Mengel
   • Sven Poli

   Review Article 08 May 2018 Pages: 823 - 831

   

5. Mirabegron: A Review in Overactive Bladder Syndrome

   • Emma D. Deeks

   Adis Drug Evaluation 04 June 2018 Pages: 833 - 844

6. Tildrakizumab: First Global Approval

   • Anthony Markham

   AdisInsight Report 11 May 2018 Pages: 845 - 849

   

7. Comment on: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”

   • Antonio Pires
   • Kavitha Goyal
   • Andrew Greenspan

   Letter to the Editor Open access 21 May 2018 Pages: 851 - 852

8. Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”

   • Hillel P. Cohen
   • Andrew Blauvelt
   • Gillian Woollett

   Letter to the Editor Open access 21 May 2018 Pages: 853 - 855

9. Correction to: Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension

   • Sheridan M. Hoy

   Correction Open access 30 May 2018 Pages: 857 - 857

10. Correction to: Ibalizumab: First Global Approval

    • Anthony Markham

    Correction Open access 30 May 2018 Pages: 859 - 859